Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page
- Check2 days agoChange DetectedA new history entry dated 2026-05-08 adds a Study Status update and Revision: v3.5.4 to the record history. The prior Revision: v3.5.3 entry from 2026-04-13 has been removed.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry (v3.5.3) has been added to the record history, and the previous revision (v3.5.2) has been removed, updating the historical record for the study.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the 2026-04-13 revision (v3.5.2). Deleted the 2026-03-16 revision (v3.5.0).SummaryDifference0.2%

- Check52 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the study record history.SummaryDifference0.0%

- Check59 days agoChange DetectedA new version entry dated 2026-03-16 with a Study Status update was added to the record history, and an entry dated 2026-02-13 was removed.SummaryDifference0.2%

- Check66 days agoChange DetectedAdded Revision: v3.4.3 to the history and removed Revision: v3.4.2 from the history.SummaryDifference0.0%

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.